Inovio Pharmaceuticals, Inc. (INO)

Inovio Pharmaceuticals Statistics

Total Valuation

INO has a market cap or net worth of $103.62 million. The enterprise value is $31.26 million.

Market Cap	103.62M
Enterprise Value	31.26M

Important Dates

The last earnings date was Thursday, November 14, 2024, after market close.

Earnings Date	Nov 14, 2024
Ex-Dividend Date	n/a

Share Statistics

INO has 26.10 million shares outstanding. The number of shares has increased by 16.75% in one year.

Current Share Class	26.10M
Shares Outstanding	26.10M
Shares Change (YoY)	+16.75%
Shares Change (QoQ)	+3.47%
Owned by Insiders (%)	1.59%
Owned by Institutions (%)	26.30%
Float	23.88M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	542.09
PB Ratio	1.41
P/TBV Ratio	1.41
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	153.67
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.88, with a Debt / Equity ratio of 0.17.

Current Ratio	3.88
Quick Ratio	3.69
Debt / Equity	0.17
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-263.84

Financial Efficiency

Return on equity (ROE) is -106.64% and return on invested capital (ROIC) is -59.76%.

Return on Equity (ROE)	-106.64%
Return on Assets (ROA)	-50.56%
Return on Capital (ROIC)	-59.76%
Revenue Per Employee	$1,667
Profits Per Employee	-$925,214
Employee Count	122
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -22.90% in the last 52 weeks. The beta is 0.83, so INO's price volatility has been lower than the market average.

Beta (5Y)	0.83
52-Week Price Change	-22.90%
50-Day Moving Average	5.61
200-Day Moving Average	8.65
Relative Strength Index (RSI)	18.60
Average Volume (20 Days)	366,570

Short Selling Information

The latest short interest is 3.50 million, so 13.43% of the outstanding shares have been sold short.

Short Interest	3.50M
Short Previous Month	3.48M
Short % of Shares Out	13.43%
Short % of Float	14.68%
Short Ratio (days to cover)	11.22

Income Statement

In the last 12 months, INO had revenue of $203,413 and -$112.88 million in losses. Loss per share was -$4.45.

Revenue	203,413
Gross Profit	-81.77M
Operating Income	-121.41M
Pretax Income	-121.64M
Net Income	-112.88M
EBITDA	-119.50M
EBIT	-121.41M
Loss Per Share	-$4.45

Balance Sheet

The company has $84.80 million in cash and $12.45 million in debt, giving a net cash position of $72.36 million or $2.77 per share.

Cash & Cash Equivalents	84.80M
Total Debt	12.45M
Net Cash	72.36M
Net Cash Per Share	$2.77
Equity (Book Value)	73.54M
Book Value Per Share	2.82
Working Capital	67.79M

Cash Flow

In the last 12 months, operating cash flow was -$110.69 million and capital expenditures -$487,832, giving a free cash flow of -$111.18 million.

Operating Cash Flow	-110.69M
Capital Expenditures	-487,832
Free Cash Flow	-111.18M
FCF Per Share	-$4.26

Margins

Gross Margin	n/a
Operating Margin	-59,685.24%
Pretax Margin	-55,491.09%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	-19,040.90%

Dividends & Yields

INO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-16.75%
Shareholder Yield	-16.75%
Earnings Yield	-108.94%
FCF Yield	-107.30%

Analyst Forecast

The average price target for INO is $16.33, which is 311.34% higher than the current price. The consensus rating is "Buy".

Price Target	$16.33
Price Target Difference	311.34%
Analyst Consensus	Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	229.75%
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on January 25, 2024. It was a reverse split with a ratio of 0.0833333:1.

Last Split Date	Jan 25, 2024
Split Type	Reverse
Split Ratio	0.0833333:1

Scores

INO has an Altman Z-Score of -21.81 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-21.81
Piotroski F-Score	1